Statements (26)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
Controlled substance schedule
|
| gptkbp:administeredBy |
gptkb:Drug_Enforcement_Administration
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:criteria |
Currently accepted medical use in treatment in the United States
Low potential for abuse relative to Schedule IV Abuse may lead to limited physical or psychological dependence relative to Schedule IV |
| gptkbp:enactedBy |
gptkb:United_States_Congress
|
| gptkbp:example |
gptkb:Lomotil
gptkb:Motofen gptkb:Parepectolin gptkb:Lyrica Cough preparations with less than 200 mg of codeine per 100 ml or per 100 g |
| https://www.w3.org/2000/01/rdf-schema#label |
Schedule V (US)
|
| gptkbp:legalStatus |
Prescription only
|
| gptkbp:partOf |
gptkb:Controlled_Substances_Act
|
| gptkbp:regulates |
Controlled substances
Analgesic drugs Antidiarrheal drugs Antitussive drugs |
| gptkbp:relatedTo |
gptkb:Schedule_III_(US)
gptkb:Schedule_I_(US) gptkb:Schedule_II_(US) Schedule IV (US) |
| gptkbp:startDate |
1970
|
| gptkbp:bfsParent |
gptkb:Lyrica
|
| gptkbp:bfsLayer |
5
|